Mahua Ghosh
Contact
Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept
- mahua@ualberta.ca
- Phone
- (780) 492-3626
Overview
Area of Study / Keywords
patient examination Patient care
About
Personal Statement:
I have a keen interest in medical education with the goal to expand scholarly focus on curriculum development and faculty development. I focus on innovative ways to implement Best Evidence Medical Education Curriculum for the promotion of the highest standards in Endocrinology subspecialty training and continuous professional learning. I closely work with RCPSC subspecialty committee, Canadian Society of Endocrinology and Diabetes Canada to ensure excellent training and professional development to shape the Endocrinology practice in Canada.
Dr. Mahua Ghosh was recruited to the Department of Medicine in 2011, having completed a PhD in pharmacology, a residency in internal medicine and subspecialty training in endocrinology. She also completed a certificate in Medical Education from the University of Dundee in 2017.
Leadership and Collaborations:
Dr. Ghosh is program director of the adult endocrinology subspecialty resident training program. She launched an Educational Complex Type 2 Diabetes/Metabolic Clinic to help increase residents’ clinical exposure. She serves on the Canadian Society of Endocrinology and Metabolism as a Council Member and a member of the Continuous Professional Development (CPD) Committee. She successfully advocated to incorporate transgender medicine as an Objective of Training for endocrinology for the Royal College of Physicians and Surgeons of Canada (RCPSC). She is working on the new RCPSC Accreditation Standards in CPD activity for endocrinologists. She is also a member of the Program Planning Committee for Diabetes Canada’s annual meeting. Locally, she is a member of the executive committee for the Edmonton chapter of Diabetes Canada."
Clinical Interests
Dr. Ghosh is full-time medical staff at the University of Alberta Hospital and leads the Multidisciplinary Complex Type 2 Diabetes clinic at the Kaye Edmonton Clinic.
Research
Dr. Ghosh’s research interest is polycystic ovarian syndrome and insulin resistance. She collaborates with Dr. Donna Vine and Dr. Spencer Proctor, Metabolic and Cardiovascular Diseases Laboratory, Molecular and Cell Biology of Lipids Scholar Group, Alberta Diabetes Institute.
Teaching
As program director for the adult endocrinology residency program, Dr. Ghosh revamped the curriculum to build strengths in all aspects of training—from the integration of social accountability, resource stewardship, transgender care and triage training, to the introduction of divisional quality improvement and quality assurance projects embedded in practice.
Featured Publications
Current Developments in Nutrition, Volume 6, Issue Supplement_1, June 2022, Page 880,. 2022 June; https://doi.org/10.1093/cdn/nzac066.010
PCOS is Associated with Increased Incidence of Co-morbidities.
Annual Meeting Steering Committee. ENDO 2022, the Georgia World Congress Center in Atlanta, GA from June 11-14, 2022. 2022 June;
Wang T., Vu A., Mereu L., Ghosh M.
Canadian Medical Association Journal . 2022 March; 194 (9):E332-E335 10.1503/cmaj.211002
Adrenal Insufficiency: Investigating Prevalence and Healthcare Utilization Using Administrative Data
Sekhon S.S., Crick K., Myroniuk T.W., Hamming K.S.C., Ghosh M., Campbell-Scherer D., Yeung R.O.
JOURNAL OF ENDOCRINOLOGY. 2021 December; 6 (4) doi.org/10.1210/jendso/bvab184
Testosterone Impairs Cardiac Function and Fatty Acid Metabolism in a PCOS-prone rodent model .
Canadian Society of Endocrinology and Metabolism Professional Conference,. 2021 November;
Detecting Early Markers of Cardiovascular Disease in High-Risk Women With and Without PCOS PCOS.
Canadian Journal of Diabetes (CJD). 2021 November;
Testosterone Mediates Cardiac Dysfunction and Impairs Fatty Acid Metabolism in Rodent Model Of Polycystic Ovary Syndrome.
Canadian J Cardiology.. 2021 October;
Donna Vine, Ethan Proctor, Olivia Weaver, Mahua Ghosh, Katerina Maximova, Spencer Proctor
3 Biotech. 2021 June; 5(9):bvab114 doi: 10.1210/jendso/bvab114. eCollection 2021 Sep
Malignant Insulinoma: Successful Medical Management in Diazoxide-Refractory Hypoglycemia
Canadian Journal of Diabetes (CJD). 2020 October;